Brantford, Canada

Randa E El-Haj


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Randa E El-Haj: Innovator in Pharmaceutical Sciences

Introduction

Randa E El-Haj is a notable inventor based in Brantford, Canada. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of novel antibiotic formulations. Her work has implications for various medical conditions, showcasing her dedication to improving healthcare outcomes.

Latest Patents

Randa E El-Haj holds a patent for "Polymorphic forms of rifaximin." This patent includes two additional forms of rifaximin, specifically rifaximin polymorphic forms APO-III and APO-IV. The patent also outlines novel processes for preparing previously disclosed rifaximin polymorphic forms APO-I and APO-II. Rifaximin is a non-aminoglycoside antibiotic that has been found useful in treating traveler's diarrhea, irritable bowel syndrome, diverticular disease, hepatic encephalopathy, pyogenic skin infections, and as an antibacterial prophylactic prior to colon surgery. She has 1 patent to her name.

Career Highlights

Randa is associated with Apotex Pharmachem Inc., where she continues to contribute to pharmaceutical innovation. Her work in developing new forms of rifaximin demonstrates her expertise and commitment to advancing medical treatments.

Collaborations

Randa has collaborated with notable colleagues, including Peter Garth Blazecka and Nageib Mohamed. These partnerships highlight the collaborative nature of research and development in the pharmaceutical industry.

Conclusion

Randa E El-Haj is a pioneering inventor whose work in antibiotic formulations is making a significant impact in the medical field. Her contributions are essential for the advancement of effective treatments for various health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…